CA SB 524 Comment Letter (2021)
PCMA delivers a comment letter to the chair of the Assembly committee on Business and Professions addressing steering and mail order proposed provisions.
OK Coalition Comment Letter to BoP (2023)
Coalition letter in opposition to a Board of Pharmacy proposed rule that would require temperature controlled packaging for all drug delivery, regardless of specific temperature
IA HF 729 Cost Analysis (2021)
If enacted, IA HF 729 would cost the state $1.2 billion over next 10 years. HF 729 would instittue Any Willing Provider rules and restrict
CA SB 524 Talking Points
Talking points addressing SB 524, a bill aimed at prohibiting PBM steering practices in California.
CA SB 524 Comment Letter
PCMA delivers a comment letter to the sponsor of SB 602, a bill that aims to prohibit PBMs ability to steer patients to lower cost,
CA SB 524 Comment Letter
PCMA provides comment letter to the CA Senate Health Committee opposing SB 524, an anti-steering bill. If enacted, the bill would prohibit PBMs from offering
PBMS are Taking Action to Promote Patient Access to Prescription Drugs During COVID-19 Pandemic
PCMA developed overiew addressing the actions PBMs are taking to address access and affordability of prescription drugs during the COVID-19 pandemic.
Visante: Increased Costs Associated With Proposed State Legislation Impacting PBM Tools (2020)
Visante was commissioned by the Pharmaceutical Care Management Association (PCMA) to estimate the potential cost impact of four types of state legislation impacting pharmacy benefit